Strzalka-Mrozik, B.;                     Paprzycka, O.;                     Gruszka, O.;                     Madej, M.;                     Kruszniewska-Rajs, C.;                     Gola, J.M.;                     Turek, A.    
        Ranibizumab Modifies the Expression of Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Mononuclear Cells in Patients with Exudative Age-Related Macular Degeneration. J. Clin. Med. 2024, 13, 295.
    https://doi.org/10.3390/jcm13010295
    AMA Style
    
                                Strzalka-Mrozik B,                                 Paprzycka O,                                 Gruszka O,                                 Madej M,                                 Kruszniewska-Rajs C,                                 Gola JM,                                 Turek A.        
                Ranibizumab Modifies the Expression of Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Mononuclear Cells in Patients with Exudative Age-Related Macular Degeneration. Journal of Clinical Medicine. 2024; 13(1):295.
        https://doi.org/10.3390/jcm13010295
    
    Chicago/Turabian Style
    
                                Strzalka-Mrozik, Barbara,                                 Olga Paprzycka,                                 Oliwia Gruszka,                                 Marcel Madej,                                 Celina Kruszniewska-Rajs,                                 Joanna Magdalena Gola,                                 and Artur Turek.        
                2024. "Ranibizumab Modifies the Expression of Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Mononuclear Cells in Patients with Exudative Age-Related Macular Degeneration" Journal of Clinical Medicine 13, no. 1: 295.
        https://doi.org/10.3390/jcm13010295
    
    APA Style
    
                                Strzalka-Mrozik, B.,                                 Paprzycka, O.,                                 Gruszka, O.,                                 Madej, M.,                                 Kruszniewska-Rajs, C.,                                 Gola, J. M.,                                 & Turek, A.        
        
        (2024). Ranibizumab Modifies the Expression of Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Mononuclear Cells in Patients with Exudative Age-Related Macular Degeneration. Journal of Clinical Medicine, 13(1), 295.
        https://doi.org/10.3390/jcm13010295